-
公开(公告)号：US20210260370A1
公开(公告)日：2021-08-26
申请号：US17182436
申请日：2021-02-23
Applicant: Boston Scientific Scimed, Inc.
Inventor： Kyle Harish Srivastava , Vijay Koya , Thomas Lee Williams , Miles Kealy , Nicholas Barron
Abstract: Embodiments herein relate to medical devices and methods for using the same to treat cancerous tumors within a bodily tissue. A medical device system herein can include an electric field generating circuit configured to generate one or more electric fields, and control circuitry. The system can include one or more electrodes disposed on a first stimulation lead to deliver the electric fields to a site of a cancerous tumor within a patient and one or more electrodes disposed on a second stimulation lead to deliver the electric fields to the site of a cancerous tumor within a patient. The first and second stimulation leads can be configured to be implanted on or about a duodenum. The electric field generating circuit can generate electric fields at frequencies selected from a range of between 10 kHz to 1 MHz. Other embodiments are also included herein.
-
公开(公告)号：US11883655B2
公开(公告)日：2024-01-30
申请号：US17182436
申请日：2021-02-23
Applicant: Boston Scientific Scimed, Inc.
Inventor： Kyle Harish Srivastava , Vijay Koya , Thomas Lee Williams , Miles Kealy , Nicholas Barron
CPC classification number: A61N1/36002 , A61N1/0509 , A61N1/08 , A61N1/36007 , A61N1/40
Abstract: Embodiments herein relate to medical devices and methods for using the same to treat cancerous tumors within a bodily tissue. A medical device system herein can include an electric field generating circuit configured to generate one or more electric fields, and control circuitry. The system can include one or more electrodes disposed on a first stimulation lead to deliver the electric fields to a site of a cancerous tumor within a patient and one or more electrodes disposed on a second stimulation lead to deliver the electric fields to the site of a cancerous tumor within a patient. The first and second stimulation leads can be configured to be implanted on or about a duodenum. The electric field generating circuit can generate electric fields at frequencies selected from a range of between 10 kHz to 1 MHz. Other embodiments are also included herein.
-
公开(公告)号：US11419560B2
公开(公告)日：2022-08-23
申请号：US16188669
申请日：2018-11-13
Applicant: Boston Scientific Scimed, Inc.
Inventor： Bryan Allen Clark , Elizabeth Mary Annoni , Sandra Nagale , Jeffrey E. Stahmann , Kyle Harish Srivastava , Mark W. Boden , Martin Phelan , George Wilfred Duval
IPC: A61B5/00 , A61B5/024 , C07K16/24 , A61B5/11 , A61K39/00 , A61B5/08 , A61B5/113 , A61B5/0205 , G16H50/30 , A61B5/021 , A61B5/0245
Abstract: An example of a system for monitoring and treating a medical condition of a patient may include signal inputs to receive patient condition signals indicative of a state of inflammatory bowel disease (IBD), a signal processing circuit configured to process the patient condition signals and generate patient condition parameters indicative of the state of IBD using the processed patient condition signals, and a medical condition analyzer configured to analyze the patient condition parameters and determine the medical condition including the state of IBD using an outcome of the analysis. The patient condition parameters may include one or more physiological marker parameters each representative of a physiological marker of IBD and one or more quality of life parameters each being measure of quality of life of the patient.
-
公开(公告)号：US20220218241A1
公开(公告)日：2022-07-14
申请号：US17707343
申请日：2022-03-29
Applicant: Boston Scientific Scimed, Inc.
Inventor： Vijay Koya , Bryan Allen Clark , Kyle Harish Srivastava , Michael X. Govea , Elizabeth Mary Annoni
Abstract: A system may include an implantable structure with a plurality of electrodes attached thereto, where the implantable structure is configured to be implanted proximate to a nerve that innervates and is proximate to an organ involved with glucose control. The system may further include a controller configured for use to control which of the plurality of electrodes are modulation electrodes and which of the plurality of electrodes are sense electrodes, a modulation energy generator configured to deliver modulation energy using one or more of the modulation electrodes, and a nerve traffic sensor configured to sense nerve traffic in the nerve using one or more of the sense electrodes. The controller may be configured to determine if the delivered modulation energy captures the nerves based on the sensed neural activity.
-
公开(公告)号：US12178645B2
公开(公告)日：2024-12-31
申请号：US16913947
申请日：2020-06-26
Applicant: BOSTON SCIENTIFIC SCIMED, INC.
Inventor： Kyle Harish Srivastava , Paul F. Chouinard , Christopher Piere , Jason A. Kilvington , Niraj Prasad Rauniyar , Brian P. Watschke
Abstract: Example ultrasound medical devices are disclosed. An example medical device includes a support member having a proximal end region and a distal end region and a sensing member having a proximal end region and a distal end region, the distal end region of the sensing member coupled to the distal end region of the support member. The medical device also includes one or more ultrasound sensors disposed along the sensing member and a support shaft having a first end coupled to the sensing member and a second end coupled to the support member. Additionally, the sensing member is configured to shift from a first configuration in which the sensing member is adjacent to the support member to a second configuration in which at least a portion of the sensing member extends away from the support member.
-
Patent Agency Ranking
公开(公告)号：US11304633B2
公开(公告)日：2022-04-19
申请号：US16178872
申请日：2018-11-02
Applicant: Boston Scientific Scimed, Inc.
Inventor： Vijay Koya , Bryan Allen Clark , Kyle Harish Srivastava , Michael X. Govea , Elizabeth Mary Annoni
IPC: A61N1/36 , A61N1/05 , A61B5/145 , A61B5/1486 , A61M5/172 , A61M5/142 , A61B5/00 , A61B5/1495
Abstract: A system may include an implantable structure with a plurality of electrodes attached thereto, where the implantable structure is configured to be implanted proximate to a nerve that innervates and is proximate to an organ involved with glucose control. The system may further include a controller configured for use to control which of the plurality of electrodes are modulation electrodes and which of the plurality of electrodes are sense electrodes, a modulation energy generator configured to deliver modulation energy using one or more of the modulation electrodes, and a nerve traffic sensor configured to sense nerve traffic in the nerve using one or more of the sense electrodes. The controller may be configured to determine if the delivered modulation energy captures the nerves based on the sensed neural activity.
-
公开(公告)号：US11266416B2
公开(公告)日：2022-03-08
申请号：US16562076
申请日：2019-09-05
Inventor： Tina Marie Lenneman , Dennis A. Boismier , Kyle Harish Srivastava , Kevin J. Goodwin , Felix Landaeta , Paige V. Tracy
Abstract: A vessel occlusion device is provided for use during a coronary artery bypass procedure. The vessel occlusion device may include a clamp including at least one rigid portion sized to be disposed around an outer surface of a vessel such as the aorta. The clamp defines a clamp lumen sized to receive the vessel. The clamp has a sidewall with an opening extending therethrough, and an inflatable balloon disposed within the clamp lumen and positioned proximal of the opening in the sidewall.
-
公开(公告)号：US20190150851A1
公开(公告)日：2019-05-23
申请号：US16188669
申请日：2018-11-13
Applicant: Boston Scientific Scimed, Inc.
Inventor： Bryan Allen Clark , Elizabeth Mary Annoni , Sandra Nagale , Jeffrey E. Stahmann , Kyle Harish Srivastava , Mark W. Boden , Martin Phelan , George Wilfred Duval
Abstract: An example of a system for monitoring and treating a medical condition of a patient may include signal inputs to receive patient condition signals indicative of a state of inflammatory bowel disease (IBD), a signal processing circuit configured to process the patient condition signals and generate patient condition parameters indicative of the state of IBD using the processed patient condition signals, and a medical condition analyzer configured to analyze the patient condition parameters and determine the medical condition including the state of IBD using an outcome of the analysis. The patient condition parameters may include one or more physiological marker parameters each representative of a physiological marker of IBD and one or more quality of life parameters each being measure of quality of life of the patient.
-
公开(公告)号：US20190125227A1
公开(公告)日：2019-05-02
申请号：US16178872
申请日：2018-11-02
Applicant: Boston Scientific Scimed, Inc.
Inventor： Vijay Koya , Bryan Allen Clark , Kyle Harish Srivastava , Michael X. Govea , Elizabeth Mary Annoni
Abstract: A system may include an implantable structure with a plurality of electrodes attached thereto, where the implantable structure is configured to be implanted proximate to a nerve that innervates and is proximate to an organ involved with glucose control. The system may further include a controller configured for use to control which of the plurality of electrodes are modulation electrodes and which of the plurality of electrodes are sense electrodes, a modulation energy generator configured to deliver modulation energy using one or more of the modulation electrodes, and a nerve traffic sensor configured to sense nerve traffic in the nerve using one or more of the sense electrodes. The controller may be configured to determine if the delivered modulation energy captures the nerves based on the sensed neural activity.
-
公开(公告)号：US20190125226A1
公开(公告)日：2019-05-02
申请号：US16178777
申请日：2018-11-02
Applicant: Boston Scientific Scimed, Inc.
Inventor： Vijay Koya , Bryan Allen Clark , Kyle Harish Srivastava , Michael X. Govea , Elizabeth Mary Annoni
Abstract: A system may include a controller operably connected to a diabetic therapy delivery system. The controller may be configured to: receive therapy inputs including a therapy input indicative of a glucose measure; determine a therapy input index using the at least one therapy input including the therapy input indicative of a glucose measure; map the determined therapy input index to a graded glucose control; and set the graded glucose control based on the mapped graded glucose control for the determined therapy input index, wherein the graded glucose control includes at least one of a neuromodulation target, a neuromodulation type, or at least one neuromodulation parameter value. The diabetic therapy delivery system may be configured to deliver the therapy for graded glucose control using the graded glucose control that was set based on the mapped graded glucose control.
-
-
-
-
-
-
-
-
-
Search Results
10
records
(took 0.031 seconds)
